JESSICA BUSSEY: Open Payments
NPI 1942750237 · HUDSON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,632 in 88 payments from 18 companies in 2025. Trend: 2023 $1,993 · 2024 $1,317 · 2025 $1,632
Food & beverage: $1,565Education: $67
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $587 |
| ABBVIE INC. | 23 | $223 |
| Amgen Inc. | 10 | $137 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| GENZYME CORPORATION | 3 | $78 |
| UCB, Inc. | 2 | $77 |
| PFIZER INC. | 4 | $69 |
| Mallinckrodt Hospital Products Inc. | 2 | $66 |
| Paratek Pharmaceuticals, Inc. | 3 | $62 |
| Galderma Laboratories, L.P. | 3 | $55 |
Products named: TREMFYA, SKYRIZI, OTEZLA, DUPIXENT, Bimzelx, CIBINQO, ACTHAR, NUZYRA.
Industry payments across FL — which companies pay providers there.
